<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
This is a federal contract award by the National Cancer Institute (NCI), a civilian agency, to Sophic Systems Alliance Inc., a small business veteran-owned contractor. The contract is for a System to Analyze and Support Biomarker Research and Development Strategies under the Small Business Innovation Research (SBIR) Program Phase II. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $745,999.90 and a period of performance ending on August...
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Quantum Mark, LLC, a woman-owned small business. The $749,995.54 cost-plus-fixed-fee contract was awarded under the Small Business Innovation Research (SBIR) Phase II program to develop software systems to facilitate the use of electronic data records in the collection of population-based cancer surveillance data. The contract has a period of performance through June 29, 2012 and was set aside for...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a...
This is a $2,250,351.00 Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a civilian agency, to Provid Pharmaceuticals Inc., a for-profit small business organization. The contract is for the MEDICINAL CHEMISTRY LEAD OPTIMIZATION, (PHASE II) SBIR TOPIC 198 research project under the Small Business Innovation Research (SBIR) program. The contract was awarded on August 31, 2005 and has an ultimate completion date of May 31, 2008. This contract is set aside for small...
<p>This federal contract award, with an identifier of HHSN261201000089C, was issued by the National Cancer Institute (NCI), a civilian agency. The contract was awarded to Dana Pharmaceutical Consulting, Inc., a small business, for a one-year, firm fixed-price SBIR Phase I research project focused on "Facilitating the Transfer of Statistical Methodology into Practice." The contract has a ceiling value of $100,000.00.</p>
This federal contract award, identified as HHSN261201100058C, was awarded to MEI Research, LTD., a small business, for the development of "TAS Systems for Automated Storage, Analysis, and Reporting of Objective Behavioral Exposures" for the National Cancer Institute (NCI), a civilian agency. The firm fixed price contract has a ceiling value of $199,554.00 and was awarded under the Small Business Innovation Research (SBIR) Program Phase I. The contract was awarded on September 23, 2011,...
This federal contract award is for the development of the ICURE system for the Center for Research on Cancer Health Disparities (CRCHD) at the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS). The prime contractor for this $137,540 Firm Fixed Price contract is MDB Inc., a small business that provides services to federal agencies including environmental health research, workforce training, and education programs. The contract was issued under the...
This federal contract award was made by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The award, valued at $1,076,616.60, is for Scientific Support Services for a Medical Officer 9 to support the Office of Sponsor and Regulatory Oversight within the NCI's Center for Cancer Research. The contract is a Blanket Purchase Agreement (BPA) Call issued under the Multiple Award Schedule (MAS) contract vehicle,...
The National Cancer Institute, a component of the Department of Health and Human Services, awarded a $489,805 firm fixed price purchase order to Biofortis, LLC. The contract provides for Biofortis Labmatrix clinical and translational research management software subscriptions, maintenance, and development support services over a base period of performance from August 2021 through August 2022. The original solicitation sought these capabilities on a sole source basis from Biofortis to provide...